Finding 565661 (2024-001)

Significant Deficiency
Requirement
I
Questioned Costs
$1
Year
2024
Accepted
2025-06-20
Audit: 359340
Organization: The Jackson Laboratory (ME)
Auditor: Kpmg LLP

AI Summary

  • Core Issue: A procurement transaction over $10,000 lacked required documentation, violating both the Laboratory’s policy and federal regulations.
  • Impacted Requirements: The failure to obtain competitive quotations and maintain proper documentation led to a questioned cost of $33,940.
  • Recommended Follow-Up: Review and enhance procurement policies, conduct annual re-education for staff, and improve access to procurement guidelines by the end of 2025.

Finding Text

Compliance Requirement: Procurement, Suspension, and Debarment Criteria: Procurement In accordance with 2 CFR Part 200 for Procurement, small purchase procedures are used for purchases that exceed the micro-purchase amount but do not exceed the simplified acquisition threshold ($250,000). If small purchase procedures are used, price or rate quotations must be obtained from an adequate number of qualified sources. Micro-purchases may be awarded without soliciting competitive quotations if the non-federal entity considers the price reasonable and maintains documents to support its conclusion. Further, in accordance with the Laboratory’s procurement policy, documentation is required, using the Laboratory’s vendor justification/price verification form, for purchases to support the price checking and vendor selection for the items being charged directly to a federal award. Condition: 30 procurement transactions were selected from all procurement transactions over $10,000 under federal awards. Of the 30 items selected, we noted 1 item did not follow the requirement to obtain and maintain documentation in accordance with the Laboratory’s policy over soliciting competitive quotations for procurements over $10,000. Possible Asserted Cause and Effect: The Laboratory did not comply with their procurement policy or the 2 CFR Part 200, Appendix XI. The review controls in place to identify such required documentation was not executed as designed and as a result an invoice was charged to a federal award without the requisite documentation. However, we note the Laboratory did identify the error in documentation after the fact, during a monitoring review conducted by internal audit in 2025. Identification of Questioned Costs: $33,940 Whether Sampling was Statistically Valid: The sample was not intended to be, and was not, a statistically valid sample. Identification of Whether the Audit Finding was a Repeat Findings: This is not a repeat finding. Recommendation: We recommend that the Laboratory review its current policies and procedures to ensure procurement transactions are reviewed and substantiated with formal documentation prior to approval of the transaction. Views of Responsible Officials: Management agrees with finding 2024-001. In fiscal year 2024 the Laboratory charged a federal sponsored award for a procurement item, which exceeded the Laboratory’s micro-purchase threshold, without maintaining the proper documentation as required by Laboratory procurement policy. In fiscal 2025 this item was identified by the Laboratory’s Internal Audit and Sponsored Programs Accounting Offices as part of their routine review program. The transaction cost was removed by Laboratory Management from the federal award within 90 days of the item’s discovery; however, because the item was identified and adjusted in 2025, the fiscal year 2024 Schedule of Expenditures of Federal Awards (SEFA) was overstated. To ensure compliance with the Laboratory’s procurement policies, the Laboratory has implemented corrective actions as detailed below, in line with the recommendation: Corrective Actions Previously Implemented: 1. The Laboratory’s Internal Audit and Sponsored Program Accounting Offices will continue to conduct regular reviews of procurement items to ensure that documentation complies with Laboratory Procurement Methods Policy and Procedure, to ensure compliance with Laboratory policy, designed to ensure compliance with 2 CFR Sections 200.317 through 200.327. The audit focus will continue to be on 100% of sponsored award procurement transactions in the small purchase threshold. 2. The Laboratory Information Technology department, in collaboration with the Laboratory’s Procurement Office Director, enhanced certain system-generated reporting to allow for easier identification by Procurement Office personnel of charges to sponsored awards. Corrective Actions to be Implemented: 1. The Laboratory’s Sponsored Programs Accounting Office, in collaboration with its Procurement Office, will provide an annual re-education to Laboratory administrative research personnel concerning Laboratory Procurement Policies, designed to ensure compliance with 2 CFR Sections 200.317 through 200.327. 2. The Sponsored Programs Accounting Office will provide re-training for administrative staff to reinforce the Laboratory Procurement Method Policies and Procedure. 3. The Director of Procurement will streamline access and visibility of the Procurement Methods Policy and Procedure on the Laboratory’s internal website. Management intends for the re-education of administrative research personnel and re-training for administrative staff to be concluded by the end of the third quarter and/or early fourth quarter of 2025. Management intends to provide for streamlined access and visibility of Laboratory Procurement Methods Policy and Procedure on its internal website prior to the end of 2025.

Corrective Action Plan

Finding 2024-001: Procurement, Suspension and Debarment Corrective Action: Management agrees with the finding. In fiscal year 2024 the Laboratory charged a federal sponsored award for a procurement item, which exceeded the Laboratory’s micro-purchase threshold, without maintaining the proper documentation as required by Laboratory procurement policy. In fiscal 2025 this item was identified by the Laboratory’s Internal Audit and Sponsored Programs Accounting Offices as part of their routine review program. The transaction cost was removed by Laboratory Management from the federal award within 90 days of the item's discovery; however, because the item was identified and adjusted in 2025, the fiscal year 2024 Schedule of Expenditures of Federal Awards (SEFA) was overstated. To ensure compliance with the Laboratory’s procurement policies the Laboratory has implemented and/or will implement certain corrective actions as detailed below, in line with the recommendation: Corrective Actions Previously Implemented: 1. The Laboratory’s Internal Audit and Sponsored Program Accounting Offices will continue to conduct regular reviews of procurement items to ensure that documentation complies with Laboratory Procurement Methods Policy and Procedure, to ensure compliance with Laboratory policy, designed to ensure compliance with 2 CFR Sections 200.317 through 200.327. The audit focus will continue to be on 100% of sponsored award procurement transactions in the small purchase threshold. 2. The Laboratory Information Technology department, in collaboration with the Laboratory’s Procurement Office Director, enhanced certain systemgenerated reporting to allow for easier identification by Procurement Office personnel of charges to sponsored awards. Corrective Actions to be Implemented: 1. The Laboratory’s Sponsored Programs Accounting Office, in collaboration with its Procurement Office, will provide an annual re-education to Laboratory administrative research personnel concerning Laboratory Procurement Policies, designed to ensure compliance with 2 CFR Sections 200.317 through 200.327. 2. The Sponsored Programs Accounting Office will provide re-training for administrative staff to reinforce the Laboratory Procurement Method Policies and Procedure. 3. The Director of Procurement will streamline access and visibility of the Procurement Methods Policy and Procedure on the Laboratory’s internal website. Management intends for the re-education of administrative research personnel and retraining for administrative staff to be concluded by the end of the third quarter and/or early fourth quarter of 2025. Management intends to provide for streamlined access and visibility of Laboratory Procurement Methods Policy and Procedure on its internal website prior to the end of 2025. Names of contact person(s) responsible for corrective action: Gerard Langlais, Corporate Controller

Categories

Questioned Costs Procurement, Suspension & Debarment

Other Findings in this Audit

  • 1142103 2024-001
    Significant Deficiency

Programs in Audit

ALN Program Name Expenditures
93.397 Cancer Centers Support Grants $2.68M
93.351 Research Infrastructure Programs $654,420
93.846 Arthritis, Musculoskeletal and Skin Diseases Research $432,037
93.867 Vision Research $405,916
47.074 Biological Sciences $365,686
93.113 Environmental Health $351,076
93.121 Oral Diseases and Disorders Research $336,273
93.859 Biomedical Research and Research Training $230,417
93.493 Congressional Directives $221,230
93.853 Extramural Research Programs in the Neurosciences and Neurological Disorders $202,209
93.242 Mental Health Research Grants $188,628
12.420 Military Medical Research and Development $165,347
93.172 Human Genome Research $128,141
93.866 Aging Research $117,616
93.855 Allergy and Infectious Diseases Research $113,133
93.398 Cancer Research Manpower $103,785
93.353 21st Century Cures Act - Beau Biden Cancer Moonshot $85,052
93.279 Drug Use and Addiction Research Programs $75,904
93.847 Diabetes, Digestive, and Kidney Diseases Extramural Research $74,702
93.RD Medical Imaging and Data Resource Center (midrc) for Rapid Response to Covid-19 Pandemic $65,075
93.350 National Center for Advancing Translational Sciences $57,333
93.310 Trans-Nih Research Support $54,277
93.368 21st Century Cures Act - Precision Medicine Initiative $49,114
93.384 Advanced Research Projects Agency for Health (arpa-H) $48,193
93.395 Cancer Treatment Research $34,965
93.396 Cancer Biology Research $28,530
93.173 Research Related to Deafness and Communication Disorders $22,022
93.838 Lung Diseases Research $15,535
93.837 Cardiovascular Diseases Research $12,684
47.049 Mathematical and Physical Sciences $11,162
93.393 Cancer Cause and Prevention Research $10,764
93.286 Discovery and Applied Research for Technological Innovations to Improve Human Health $10,624
93.233 National Center on Sleep Disorders Research $9,436
93.865 Child Health and Human Development Extramural Research $1,869